Jane Street’s Oruka Therapeutics ORKA Stock Holding History

Jane Street’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.25M	Buy	+66,200	New	+$2.3M	﹤0.01%	4202
2025 Q4	–	Sell	-56,200	Closed	-$1.08M	–	12698
2025 Q3	$1.08M	Buy	+56,200	New	+$833K	﹤0.01%	6156

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Jane Street's ORKA Position: Q1 2025 in Review

Jane Street sold out of Oruka Therapeutics (ORKA) in Q1 2025, closing a stake of 17,706 shares — an estimated $343K sold.

Jane Street first reported a position in ORKA in Q4 2022 and held it in 2 quarters. The position peaked at $343K in Q4 2024. 71 funds tracked by Wall St. Rank hold ORKA as of Q1 2025.

Jane Street reported no remaining Oruka Therapeutics position as of Q1 2025 after selling out during the quarter.
Jane Street sold 17,706 Oruka Therapeutics shares in Q1 2025, an estimated $343K.
Jane Street first reported a position in Oruka Therapeutics in Q4 2022 and held it in 2 quarters.
Jane Street's Oruka Therapeutics position peaked at $343K in Q4 2024.
71 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.